SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): April 15, 2002
NUTRACEUTIX, INC.
(Exact name of registrant as specified in its charter)
Delaware (State or other jurisdiction of incorporation) |
000-24693 (Commission File Number) |
91-1689591 (I.R.S. Employer Identification No.) |
8340 154th Avenue NE, Redmond, Washington (Address of principal executive offices) |
98052 (Zip Code) |
Registrants telephone number, including area code: (425) 883-9518
Item 5. Other Events. | ||||||||
Item 7. Financial Statements and Exhibits. | ||||||||
SIGNATURES | ||||||||
Exhibit 99 |
Item 5. Other Events.
On April 15, 2002, the registrant issued a press release reporting that Carl W. Schafer had resigned from the Companys board of directors for personal reasons. The press release is filed herewith as Exhibit 99.
Item 7. Financial Statements and Exhibits.
(c) Exhibits.
The following exhibits are filed herewith and this list constitutes the exhibit index:
Exhibit No. | Description | |
99 | Nutraceutix, Inc. Press Release, April 15, 2002 |
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
NUTRACEUTIX, INC. | ||||||||
Date: | 04/25/02 | By:/s/David T. Howard | ||||||
|
||||||||
David T. Howard President and Chief Executive Officer |
-2-